Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05202223 · ClinicalTrials.gov registry record · NA

Harmony at Home: A Pilot Telehealth Program for Rural ADRD Caregivers

A NA study of Alzheimer Disease and Dementia, sponsored by Elizabeth K Rhodus.

Completed
Registry status
NA
Development phase
80
Enrollment target
1
Study location

NCT05202223: Completed NA study of Alzheimer Disease and Dementia, sponsored by Elizabeth K Rhodus.

NCT05202223 is a NA study of Alzheimer Disease and Dementia that has completed, run by Elizabeth K Rhodus. The registered enrollment target is 80 participants, below the 2,750-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05202223, a NA study of Alzheimer Disease and Dementia, has completed, sponsored by Elizabeth K Rhodus.

COMPLETED
Registry status
NA
Development phase
80 participants
Enrollment target
1
Study location

Study Summary

There is a need for caregiver-initiated and -implemented non-pharmacological interventions directly to and for the person with dementia, including environmental assessment and modification, as first-line treatments for behavioral and psychological symptoms of dementia (BPSD) in persons living with dementia (PLWD). Delivered via telehealth, Harmony at HOME (H@H) aims to train caregivers of persons with moderate to severe ADRD in the skills of assessing and modifying the home environment to promote "person-environment fit," a concept that posits that the ability to access features within a built environment (e.g. bathroom, stairs,) or that factors within the environment itself (lighting, noise level, temperature), especially when linked with individualized social support, contribute to or even shape behavior. In addition to the intervention, the first 10 caregiver participants to enroll will also be invited to participate in two focus groups that will be facilitated during and after the intervention. The first focus group focuses on experiences as a dementia caregiver in rural areas. The second focus group focuses on providing feedback regarding caregivers' perceptions, acceptability, and usefulness of the H@H intervention. These focus groups will be conducted as structured interviews with open-ended questions that encourage participants to share their experiences.

Primary Outcome

Pearlin Mastery Scale: A 4-item scale measuring the extent to which a participant sees life as being under his/her personal control vs. something that is fatalistically ruled. Scores range from 4 to 16, with higher scores indicating greater levels of mastery.

Interventions

  • BEHAVIORAL Harmony at HOME (H@H)

Study Locations (1)

Kentucky

  • University of Kentucky - Lexington

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2022-01-15
Est. Completion 2022-12-08
Phase NA
Elizabeth K Rhodus

3 total trials

What the finished NCT05202223 record still lists

NCT05202223 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 2,750-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (97% lower).

The record links to 9 conditions, with Alzheimer Disease appearing as the primary indexed condition, and to 1 intervention - of which Harmony at HOME (H@H) is the first listed.

NCT05202223 reports a single indexed study location in Kentucky.

Frequently Asked Questions

What is clinical trial NCT05202223 about?

NCT05202223 is a clinical study titled "Harmony at Home: A Pilot Telehealth Program for Rural ADRD Caregivers". There is a need for caregiver-initiated and -implemented non-pharmacological interventions directly to and for the person with dementia, including environmental assessment and modification, as first-line treatments for behavioral and psychological symptoms of dementia (BPSD) in persons living with d...

What is the current status of trial NCT05202223?

This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2022-01-15. Estimated completion is 2022-12-08.

What conditions does trial NCT05202223 study?

This clinical trial studies the following conditions: Alzheimer Disease, Dementia, Mental Disorders, Nervous System Diseases, Central Nervous System Diseases.

What interventions are being tested in trial NCT05202223?

The interventions under investigation include: Harmony at HOME (H@H) (BEHAVIORAL).

Who is sponsoring clinical trial NCT05202223?

This trial is sponsored by Elizabeth K Rhodus, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05202223 being conducted?

This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Alzheimer Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05202223's enrollment target sits among peer trials

80 168th of 306 higher than 134 of 306 other Alzheimer Disease trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Alzheimer Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01243931 · 80 participants · NA

    Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy

  • NCT01659203 · 80 participants · Phase 1

    Proton or Photon RT for Retroperitoneal Sarcomas

  • NCT01803451 · 80 participants · Early Phase 1

    Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass

  • NCT01964859 · 80 participants · Phase 2

    Feasibility Study for Fibroblast Autologous Skin Grafts

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05202223, the US trial registry maintained by the National Library of Medicine. NCT05202223 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.